Advanced Instruments has announced the acquisition of Solentim for approximately $240 million. The closing of the transaction is expected during the third quarter of 2021.
Solentim is the trusted global leader in workflows for antibody and cell-based therapies. Solentim’s assurance rich technologies enable the isolation, growth and characterization of high value cells while its data-driven platform enables smarter decision making earlier in the cell line development process.
Patricia Industries is a long-term owner that invests in companies and works to develop each company to its full potential. Patricia Industries is a part of the industrial holding company Investor AB, whose main owner is the Wallenberg Foundations.
Advanced Instruments is the leading global provider of osmolality testing instrumentation and consumables for the clinical, biopharmaceutical, and food and beverage markets. With a strong brand reputation and deep customer relationships, it is recognized as the global authority on osmolality testing, and its products are the standard within each of its core markets. Advanced Instruments is based in Norwood, Massachusetts and is majority owned by Patricia Industries, a part of Investor AB.
The Simpson Thacher team included Derek Baird (Picture), Michael T. Holick, Surya Banerjee, Carlo Pia and Jess Yoon (M&A); Yash Rupal and Ellie Verran (Tax); David Vann, Ross Ferguson, Sara Razi and Kelly Karapetyan (Regulatory); and Vanessa Burrows (Healthcare).
Involved fees earner: Derek Baird – Simpson Thacher & Bartlett; Surya Banerjee – Simpson Thacher & Bartlett; Vanessa Burrows – Simpson Thacher & Bartlett; Michael Holick – Simpson Thacher & Bartlett; Kelly Karapetyan – Simpson Thacher & Bartlett; Carlo Pia – Simpson Thacher & Bartlett; Sara Razi – Simpson Thacher & Bartlett; Yash Rupal – Simpson Thacher & Bartlett; David Vann – Simpson Thacher & Bartlett; Ellie Verran – Simpson Thacher & Bartlett; Jess JuYoung Yoon – Simpson Thacher & Bartlett;
Law Firms: Simpson Thacher & Bartlett;